157 related articles for article (PubMed ID: 23898884)
1. Clinical implications of DLL4 expression in gastric cancer.
Ishigami S; Arigami T; Uenosono Y; Okumura H; Kurahara H; Uchikado Y; Setoyama T; Kita Y; Kijima Y; Nishizono Y; Nakajo A; Owaki T; Ueno S; Natsugoe S
J Exp Clin Cancer Res; 2013 Jul; 32(1):46. PubMed ID: 23898884
[TBL] [Abstract][Full Text] [Related]
2. Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells.
Li GG; Li L; Li C; Ye LY; Li XW; Liu DR; Bao Q; Zheng YX; Xiang DP; Chen L; Chen J
World J Gastroenterol; 2013 Jul; 19(28):4486-94. PubMed ID: 23901223
[TBL] [Abstract][Full Text] [Related]
3. DLL4 overexpression increases gastric cancer stem/progenitor cell self-renewal ability and correlates with poor clinical outcome via Notch-1 signaling pathway activation.
Miao ZF; Xu H; Xu HM; Wang ZN; Zhao TT; Song YX; Xu YY
Cancer Med; 2017 Jan; 6(1):245-257. PubMed ID: 27891816
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of DLL4 expression in papillary thyroid cancer.
Zhang YZ; Qin F; Han ZG; Liu Q; Zhou L; Wang YW
Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2901-5. PubMed ID: 26241546
[TBL] [Abstract][Full Text] [Related]
5. Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway.
Sun HW; Wu C; Tan HY; Wang QS
Hepatogastroenterology; 2012 May; 59(115):924-9. PubMed ID: 22020917
[TBL] [Abstract][Full Text] [Related]
6. Expression of Delta-like protein 4 in the human endometrium.
Mazella J; Liang S; Tseng L
Endocrinology; 2008 Jan; 149(1):15-9. PubMed ID: 17916635
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer.
Kim DH; Lee S; Kang HG; Park HW; Lee HW; Kim D; Yoem DH; Ahn JH; Ha E; You WK; Lee SH; Kim SJ; Chun KH
BMB Rep; 2020 Nov; 53(10):533-538. PubMed ID: 32580836
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma.
Yoon HA; Noh MH; Kim BG; Han JS; Jang JS; Choi SR; Jeong JS; Chun JH
World J Gastroenterol; 2011 Sep; 17(35):4023-30. PubMed ID: 22046092
[TBL] [Abstract][Full Text] [Related]
9. Delta-like ligand 4 (Dll4) predicts the prognosis of clear cell renal cell carcinoma, and anti-Dll4 suppresses tumor growth in vivo.
Hu GH; Liu H; Lai P; Guo ZF; Xu L; Yao XD; Zheng JH; Liu M; Xu YF
Int J Clin Exp Pathol; 2014; 7(5):2143-52. PubMed ID: 24966922
[TBL] [Abstract][Full Text] [Related]
10. Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis.
Huang QB; Ma X; Li HZ; Ai Q; Liu SW; Zhang Y; Gao Y; Fan Y; Ni D; Wang BJ; Zhang X
Oncotarget; 2014 May; 5(10):3066-75. PubMed ID: 24931473
[TBL] [Abstract][Full Text] [Related]
11. Clinico-pathological significance of exosome marker CD63 expression on cancer cells and stromal cells in gastric cancer.
Miki Y; Yashiro M; Okuno T; Kuroda K; Togano S; Hirakawa K; Ohira M
PLoS One; 2018; 13(9):e0202956. PubMed ID: 30222750
[TBL] [Abstract][Full Text] [Related]
12. Elevated DLL4 expression is correlated with VEGF and predicts poor prognosis of nasopharyngeal carcinoma.
Zhang JX; Cai MB; Wang XP; Duan LP; Shao Q; Tong ZT; Liao DZ; Li YY; Huang MY; Zeng YX; Shao JY
Med Oncol; 2013 Mar; 30(1):390. PubMed ID: 23275120
[TBL] [Abstract][Full Text] [Related]
13. High delta-like ligand 4 (DLL4) is correlated with peritumoral brain edema and predicts poor prognosis in primary glioblastoma.
Qiu XX; Chen L; Wang CH; Lin ZX; Zhou CF; Liu SY; Wang XF; Chen YP
Medicine (Baltimore); 2014 Aug; 93(8):e57. PubMed ID: 25121357
[TBL] [Abstract][Full Text] [Related]
14. Delta-like ligand 4 (DLL4) in the plasma and neoplastic tissues from breast cancer patients: correlation with metastasis.
Kontomanolis E; Panteliadou M; Giatromanolaki A; Pouliliou S; Efremidou E; Limberis V; Galazios G; Sivridis E; Koukourakis MI
Med Oncol; 2014 May; 31(5):945. PubMed ID: 24696220
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia.
Al Haj Zen A; Oikawa A; Bazan-Peregrino M; Meloni M; Emanueli C; Madeddu P
Circ Res; 2010 Jul; 107(2):283-93. PubMed ID: 20508179
[TBL] [Abstract][Full Text] [Related]
16. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer.
Jubb AM; Turley H; Moeller HC; Steers G; Han C; Li JL; Leek R; Tan EY; Singh B; Mortensen NJ; Noguera-Troise I; Pezzella F; Gatter KC; Thurston G; Fox SB; Harris AL
Br J Cancer; 2009 Nov; 101(10):1749-57. PubMed ID: 19844231
[TBL] [Abstract][Full Text] [Related]
17. Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4.
Huang QB; Ma X; Zhang X; Liu SW; Ai Q; Shi TP; Zhang Y; Gao Y; Fan Y; Ni D; Wang BJ; Li HZ; Zheng T
PLoS One; 2013; 8(6):e67294. PubMed ID: 23826258
[TBL] [Abstract][Full Text] [Related]
18. The Vascular Notch Ligands Delta-Like Ligand 4 (DLL4) and Jagged1 (JAG1) Have Opposing Correlations with Microvascularization but a Uniform Prognostic Effect in Primary Glioblastoma: A Preliminary Study.
Qiu XX; Chen L; Wang CH; Lin ZX; Chen BJ; You N; Chen Y; Wang XF
World Neurosurg; 2016 Apr; 88():447-458. PubMed ID: 26546995
[TBL] [Abstract][Full Text] [Related]
19. DLL4 as a predictor of pelvic lymph node metastasis and a novel prognostic biomarker in patients with early-stage cervical cancer.
Yang S; Liu Y; Xia B; Deng J; Liu T; Li Q; Yang Y; Wang Y; Ning X; Zhang Y; Xiao M
Tumour Biol; 2016 Apr; 37(4):5063-74. PubMed ID: 26546434
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of TAP1 and DLL4 Expression in Patients With Locally Advanced Gastric Cancer.
Segami K; Aoyama T; Hiroshima Y; Komori K; Hashimoto I; Watanabe H; Kano K; Nagasawa S; Nakazono M; Maezawa Y; Fujikawa H; Numata M; Yamada T; Tamagawa H; Yamamoto N; Ogata T; Siozawa M; Yukawa N; Morinaga S; Rino Y; Masuda M; Miyagi Y; Saeki H; Oshima T
In Vivo; 2021; 35(5):2771-2777. PubMed ID: 34410967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
